Diabetes mellitus during pregnancy — complications for the fetus and newborn

Abstract

Currently, diabetes mellitus is considered one of the most common problems in obstetrics and neonatology, associated with its high incidence and complications it causes — perinatal loss and morbidity of newborns, as well as further negative consequences for the child’s health. The incidence of diabetes mellitus is increasing in the world every year. According to forecasts of the International Diabetes Federation, there is no tendency to decrease the incidence in the near future. The increase in the incidence of diabetes mellitus is also due to a change in the criteria for diagnosis set out in the Gestational Diabetes Mellitus Treatment Guidelines. In addition, patients often do not understand the seriousness of the complications that occur with the disease, thereby not following the doctor’s treatment recommendations. To date, it has been proven that diabetes mellitus is a main cause of perinatal morbidity and mortality. According to the World Health Organization, even slight hyperglycemia in the mother during pregnancy is associated with the development of diabetic fetopathy.

This article provides an analytical review of current literature covering the issues of perinatal and neonatal outcomes in the presence of diabetic fetopathy. Its characteristic phenotypic signs include macrosomia (due to increased fat deposition in subcutaneous tissue associated with increased production of somatotropic hormone) or microsomia (due to primary placental insufficiency), general pastiness, skin hyperemia, characteristic сushingoid-type appearance, body disproportion, puffy face in combination with other signs of immaturity, as well as transient hypertrophic cardiomyopathy and hepatosplenomegaly.

Keywords

diabetes mellitus / diabetic fetopathy / fetal macrosomia / cardiopathy

References

[1] Russian Association of Endocrinologists. Russian Society of Obstetricians and Gynecologists. Gestational diabetes mellitus. Diagnosis, treatment, obstetric management tactics, postpartum care. Clinical recommendations. Moscow, 2020. Available from: https://roag-portal.ru/clinical_recommendations/ (In Russ.)

[2] Российская ассоциация эндокринологов. Российское общество акушеров-гинекологов. Гестационный сахарный диабет. Диагностика, лечение, акушерская тактика ведения, послеродовое наблюдение. Клинические рекомендации. Москва, 2020. Режим доступа: https://roag-portal.ru/clinical_recommendations/. Дата обращения: 01.05.2023.

[3] Mischenko OI, Kryukov AM, Moyses KB, et al. Diabetic fetopathy — pathogenesis, prognosis, perinatal and neonatal outcomes. Mother and Baby in Kuzbass. 2020; 1(80):4–9. EDN: SQYDZI DOI: 10.24411/2686-7338-2020-10002

[4] Мищенко О.И., Крюков П.М., Мозес К.Б., и др. Диабетическая фетопатия — патогенез, прогнозирование, перинатальные и неонатальные исходы // Мать и Дитя в Кузбассе. 2020. № 1(80). С. 4–9. EDN: SQYDZI doi: 10.24411/2686-7338-2020-10002

[5] Garcia-Flores J, Cruceyra M, Cañamares M, et al. Weight-related and analytical maternal factors in gestational diabetes to predict birth weight and cord markers of diabetic fetopathy. Gynecol Endocrinol. 2016;32(7):548–552. doi: 10.3109/09513590.2016.1138461

[6] Garcia-Flores J., Cruceyra M., Cañamares M., et al. Weight-related and analytical maternal factors in gestational diabetes to predict birth weight and cord markers of diabetic fetopathy // Gynecol Endocrinol. 2016. Vol. 32, N. 7. P. 548–552. doi: 10.3109/09513590.2016.1138461

[7] Litvinenko IA, Karpova EV, Kotaysh GA, et al. Prediction of perinatal outcomes in pregnant women with gestational diabetes. RUDN Journal of Medicine. 2011;(6):306–315.

[8] Литвиненко И.А., Карпова Е.В., Котайш Г.А., и др. Прогнозирование перинатальных исходов у беременных с гестационным диабетом // Вестник РУДН. Серия: Медицина. 2011. № 6. С. 306–315.

[9] Bush NC, Chandler-Laney PC, Rouse DJ, et al. Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered beta-cell function. J Clin Endocrinol Metab. 2011;96(5):803–809. doi: 10.1210/jc.2010-2902

[10] Bush N.C., Chandler-Laney P.C., Rouse D.J., et al. Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered beta-cell function // J Clin Endocrinol. Metab. 2011. Vol. 96, N. 5. P. 803–809. doi: 10.1210/jc.2010-2902

[11] Nikitina IL, Konoplya IS, Polyanskaya AA, et al. Characteristics of physical and psychomotor development of children born to mothers with gestational diabetes mellitus. Medical advice. 2017;9:14–20. EDN: ZCIRJX doi: 10.21518/2079-701X-2017-9-14-20

[12] Никитина И. Л., Конопля И. С., Полянская А. А., и др. Характеристика физического и психомоторного развития детей, рожденных от матерей с гестационным сахарным диабетом // Медицинский совет. 2017. № 9. С. 14–20. EDN: ZCIRJX doi: 10.21518/2079-701X-2017-9-14-20

[13] Klimov LJa, Alaverdjan LS, Verisokina NE. Сlinical-anthropometric and laboratory parameters of newborns from mothers with impaired glucose metabolism. Medical Bulletin of the North Caucasus. 2018;13(2):359–363. EDN: XTWXNZ doi: 10.14300/mnnc.2018.13049

[14] Климов Л.Я., Алавердян Л.С., Верисокина Н.Е. Клинико-антропометрические и лабораторные показатели новорожденных от матерей с нарушениями метаболизма глюкозы // Медицинский вестник Северного Кавказа. 2018. Т. 13, № 2. С. 359–363. EDN: XTWXNZ doi: 10.14300/mnnc.2018.13049

[15] Dervisoglu P, Kosecik M, Kumbasar S. Effects of gestational and pregestational diabetes mellitus on the fetal heart: a cross-sectional study. J Obstet Gynaecol. 2018;38(3):408–412. doi: 10.1080/01443615.2017.1410536

[16] Dervisoglu P., Kosecik M., Kumbasar S. Effects of gestational and pregestational diabetes mellitus on the fetal heart: a cross-sectional study // J Obstet Gynaecol. 2018. Vol. 38, N. 3. P. 408–412. doi: 10.1080/01443615.2017.1410536

[17] Putilova TA, Dan’kova IV, Tret’jakova TB. Features of the development of the cardiovascular system in the fetus with diabetic fetopathy. Russian Bulletin of the obstetrician-gynecologist. 2022;22(6):42–47. EDN: IGZQRX doi: 10.17116/rosakush20222206142

[18] Путилова Т.А., Данькова И.В., Третьякова Т.Б. Особенности развития сердечно-сосудистой системы у плода при диабетической фетопатии // Российский вестник акушера-гинеколога. 2022. Т. 22, № 6. С. 42–47. EDN: IGZQRX doi: 10.17116/rosakush20222206142

[19] El-Ganzoury MM, El-Masry SA, El-Farrash RA. Abdellatife infants of diabetic mothers: echocardiographic measurements and cord blood IGF-I and IGFBP-1. Pediatr Diab. 2012;13(2):189–196. doi: 10.1111/j.1399-5448.2011.00811.x

[20] El-Ganzoury M.M., El-Masry S.A., El-Farrash R.A. Abdellatife infants of diabetic mothers: echocardiographic measurements and cord blood IGF-I and IGFBP-1 // Pediatr Diab. 2012. Vol. 13, N. 2. P. 189–196. doi: 10.1111/j.1399-5448.2011.00811.x

[21] Wang H-Q, Lai H-L, Li Y, et al. The Relationship between maternal gestational impaired glucose tolerance and risk of large-for-gestational-age infant: a meta-analysis of 14 studies. J Clin Res Pediatr Endocrinol. 2016;8(3):264–269. doi: 10.4274/jcrpe.2583

[22] Wang H.Q., Lai H.L., Li Y., et al. The relationship between maternal gestational impaired glucose tolerance and risk of large-for-gestational-age infant: a meta-analysis of 14 studies // J Clin Res Pediatr Endocrinol. 2016. Vol. 8, N. 3. P. 264–269. doi: 10.4274/jcrpe.2583

[23] Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015; 66(2):14–20. doi: 10.1159/000371628

[24] Kc K., Shakya S., Zhang H. Gestational diabetes mellitus and macrosomia: a literature review // Ann Nutr Metab. 2015. Vol. 66, N. 2. P. 14–20. doi: 10.1159/000371628

[25] Leipold H, Worda C, Schwindt J, et al. Severe diabetic fetopathy despite strict metabolic control. Klin Wien Wochenschr. 2005;117(15–16):561–564. doi: 10.1007/s00508-005-0412-1

[26] Leipold H., Worda C., Schwindt J., et al. Severe diabetic fetopathy despite strict metabolic control // Klin Wien Wochenschr. 2005. Vol. 117, N. 15–16. P. 561–564. doi: 10.1007/s00508-005-0412-1

[27] Schäfer-Graf UM, Wöckel A. Severe diabetic fetopathy due to undiagnosed gestational diabetes mellitus. Dtsch Med Wochenschr. 2006;131(20):1151–1154. doi: 10.1055 /s-2006-94174

[28] Schäfer-Graf U.M., Wöckel A. Severe diabetic fetopathy due to undiagnosed gestational diabetes mellitus // Dtsch Med Wochenschr. 2006. Vol. 131, N. 20. P. 1151–1154. doi: 10.1055 /s-2006-941742

[29] Lysenko SN, Petruhin VA, Chechneva MA, et al. The fetal pancreas in normal and diabetes mellitus-complicated pregnancy. Vrach. 2013;(8):62–64. EDN: RAEIEL

[30] Лысенко С.Н., Петрухин В.А., Чечнева М.А. Поджелудочная железа плода при нормальном и осложненном сахарным диабетом течении беременности // Врач. 2013. № 8. С. 62–64. EDN: RAEIEL

[31] Mohsin F, Khan S, Baki MA, et al. Neonatal management of pregnancy complicated by diabetes. J Pak Med Assoc. 2016;66(9 Suppl 1):S81–S84.

[32] Mohsin F., Khan S., Baki M.A., et al. Neonatal management of pregnancy complicated by diabetes // J Pak Med Assoc. 2016. Vol. 66, N. 9 ( suppl. 1). P. S81–S84.

[33] Ermakova LB, Chechneva MA, Lysenko SN, et al. Fetal circulation in maternal diabetes mellitus. Russian Bulletin of the obstetrician-gynecologist. 2016; 16(3):16–22. EDN: WDGORH

[34] Ермакова Л.Б., Чечнева М.А., Лысенко С.Н., и др. Состояние кровообращения у плодов при сахарном диабете матери // Российский вестник акушера-гинеколога. 2016. Т. 16, № 3. С. 16–22. EDN: WDGORH

[35] Lysenko SN, Ermakova LB, Chechneva MA, et al. Specific features of fetal cardiac performance in diabetic and healthy pregnant women. Russian Bulletin of the obstetrician-gynecologist. 2016;16(4):15–20. EDN: UDDXEA doi: 10.17116/rosakush201616415-20

[36] Лысенко С.Н., Ермакова Л.Б., Чечнева М.А., и др. Особенности работы сердца плода у беременных с сахарным диабетом и у здоровых беременных // Российский вестник акушера-гинеколога. 2016. Т. 16, № 4. С. 15–20. EDN: UDDXEA doi: 10.17116/rosakush201616415-20

[37] Ahmetova ES, Lareva NV, Mudrov VA, et al. Features of pregnancy with gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of obstetrics and women’s diseases. 2017;66(4):14–24. EDN: ZDBAAF doi: 10.17816/JOWD66414-24

[38] Ахметова Е.С., Ларева Н.В., Мудров В.А., и др. Особенности течения беременности при гестационном сахарном диабете и прогнозирование диабетической фетопатии // Журнал акушерства и женских болезней. 2017. Т. 66, № 4. С. 14–24. EDN: ZDBAAF doi: 10.17816/JOWD66414-24

[39] Zaharova SJu, Kutjavina TA, Derjabina EG. The state of physical development, the level of glycemia and the lipid profile of blood in children of the first year of life, born in women with type 1 diabetes. Treatment and prevention. 2018;8(1):37–42. EDN: USBSUM

[40] Захарова С.Ю., Кутявина Т.А., Дерябина Е.Г. Состояние физического развития, уровня гликемии и показателей липидного спектра крови у детей первого года жизни, родившихся у женщин с сахарным диабетом 1 типа // Лечение и профилактика. 2018. Т. 8, № 1(25). С. 37–42. EDN: USBSUM

[41] Bogatyreva LN, Albakova MH, Albakova HA. Diabetic embryopathy of newborns: definition, etiology, pathogenesis, clinical picture, diagnosis, treatment, prevention. Modern science: actual problems of theory and practice. Series: natural and technical sciences. 2019;(3):149–151. EDN: FUQIFZ

[42] Богатырева Л.Н., Албакова М.Х., Албакова Х.А. Диабетическая эмбрионопатия новорожденных: определение, этиология, патогенез, клиническая картина, диагностика, лечение, профилактика // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2019. № 3. С. 149–151. EDN: FUQIFZ

[43] Stoyanov GS, Kobakova I, Stoev L, et al. Histological changes in severe diabetic fetopathy: an autopsy case report. Cureus. 2019;11(3). doi: 10.7759/cureus.4199

[44] Stoyanov G.S., Kobakova I., Stoev L., et al. Histological changes in severe diabetic fetopathy: an autopsy case report // Cureus. 2019. Vol. 11, N. 3. doi: 10.7759/cureus.4199

[45] Sviridova MI, Starceva NM, Romm NP. Diabetic fetopathy as an outcome of manifest diabetes mellitus first detected during pregnancy. Effective pharmacotherapy. 2020;16(26):44–49. EDN: OLEENX doi: 10.33978/2307-3586-2020-16-26-44-49

[46] Свиридова М.И., Старцева Н.М., Ромм Н.П., и др. Диабетическая фетопатия как исход манифестного сахарного диабета, впервые выявленного во время беременности // Эффективная фармакотерапия. 2020. Т. 16, № 26. С. 44–49. EDN: OLEENX doi: 10.33978/2307-3586-2020-16-26-44-49

[47] Mrudhula Tejaswi G, Samanth J, Vasudeva A, et al. Fetal echocardiography at term in diabetic pregnancies helps predict the adverse neonatal outcome — results of a prospective observational study from South India. Indian Heart J. 2020;72(6):576–581. doi: 10.1016/j.ihj.2020.09.017

[48] Mrudhula Tejaswi G., Samanth J., Vasudeva A., et al. Fetal echocardiography at term in diabetic pregnancies helps predict the adverse neonatal outcome — results of a prospective observational study from South India // Indian Heart J. 2020. Vol. 72, N. 6. P. 576–581. doi: 10.1016/j.ihj.2020.09.017

[49] Lysenko SN, Chechneva MA, Petrukhin VA, et al. The importance of cardiotocography for the diagnosis of diabetic fetal cardiomyopathy. Russian Bulletin of Obstetrician Gynecologist. 2020;20(4):41–46. EDN: CJLKJW doi: 10.17116/rosakush20202004141

[50] Лысенко С.Н., Чечнева М.А., Петрухин В.А., и др. Значение кардиотокографии для диагностики диабетической кардиомиопатии плода // Российский вестник акушера-гинеколога. 2020. Т. 20, № 4. С. 41–46. EDN: CJLKJW doi: 10.17116/rosakush20202004141

[51] Panov AE, Petrukhin VA, Chechneva MA, et al. Comparison of the effectiveness of various ultrasound fetometric percentile scales for early diagnosis of fetal macrosomia in patients with gestational diabetes mellitus. Russian Bulletin of Obstetrician Gynecologist. 2021;21(4):67–74. EDN: WNNDBX doi: 10.17116/rosakush20212104167

[52] Панов А.Е., Петрухин В.А., Чечнева М.А., и др. Сравнение информативности различных ультразвуковых фетометрических перцентильных шкал для ранней диагностики макросомии плода у беременных с гестационным сахарным диабетом // Российский вестник акушера-гинеколога. 2021. Т. 21, № 4. С. 67–74. EDN: WNNDBX doi: 10.17116/rosakush20212104167

[53] Pavlova TV, Petrukhin VA, Kaplin AN, et al. New approaches in assessing the clinical and pathomorphological aspects of obstetric pathology in the structure of the mother-placenta-fetus using atomic force microscopy. Russian Bulletin of Obstetrician Gynecologist. 2021;21(1):16–21. EDN: QAONNT doi: 10.17116/rosakush20212101116

[54] Павлова Т.В., Петрухин В.А., Каплин А.Н., и др. Новые подходы в оценке клинико-патоморфологических аспектов акушерской патологии в структуре мать – плацента – плод с применением атомно-силового исследования // Российский вестник акушера-гинеколога. 2021. Т. 21, № 1. С. 16–21. EDN: QAONNT doi: 10.17116/rosakush20212101116

[55] Kapustin RV, Kopteeva EV, Arzhanova ON, et al. The hemostatic parameters in pregnant women with different types of diabetes mellitus. Diabetes mellitus. 2021;24(3):251–261. EDN: EJHHZM doi: 10.14341/DM12682

[56] Капустин Р.В., Коптеева Е.В., Аржанова О.Н., и др. Особенности состояния коагуляционного и сосудисто-тромбоцитарного звена гемостаза у беременных с различными типами сахарного диабета // Сахарный диабет. 2021. Т. 24, № 3. С. 251–261. EDN: EJHHZM doi: 10.14341/DM12682

[57] Kopylov AT, Papysheva O, Gribova I, et al. Severe types of fetopathy are associated with changes in the serological proteome of diabetic mothers. Medicine. 2021;100(45). doi: 10.1097/MD.0000000000027829

[58] Kopylov A.T., Papysheva O., Gribova I., et al. Severe types of fetopathy are associated with changes in the serological proteome of diabetic mothers // Medicine. 2021. Vol. 100, N. 45. doi: 10.1097/MD.0000000000027829

[59] Depla AL, De Wit L, Steenhuis TJ, et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57(4):539–550. doi: 10.1002/uog.22163

[60] Depla A.L., De Wit L., Steenhuis T.J., et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis // Ultrasound Obstet Gynecol. 2021. Vol. 57, N. 4. P. 539–550. doi: 10.1002/uog.22163

[61] Şenol G, Aslan Çetin B, Esin D, et al. Evaluation of right side fetal myocardial performance index in pregestational and gestational diabetes mellitus. J Obstet Gynaecol. 2022;42(1):91–96. doi: 10.1080/01443615.2021.1882971

[62] Şenol G., Aslan Çetin B., Esin D., et al. Evaluation of right side fetal myocardial performance index in pregestational and gestational diabetes mellitus // J Obstet Gynaecol. 2022. Vol. 42, N. 1. P. 91–96. doi: 10.1080/01443615.2021.1882971

[63] Kaverzina MS. Assessment of the functional status of newborns born to mothers with gestational diabetes mellitus. Scientist. 2022;2(20):26–30. EDN: UPUQGO

[64] Каверзина М.С. Оценка функционального состояния новорожденных детей, рожденных от матерей с гестационным сахарным диабетом // Scientist. 2022. Т. 20, № 2. С. 26–30. EDN: UPUQGO

[65] Sánchez-Martínez KL, Oseguera-Torres LF, Ávalos-Nuño J. Relationship between the level of maternal glycated hemoglobin and fetal hypertrophic cardiomyopathy. Rev Med Inst Mex Seguro Soc. 2016;54(3):260–269.

[66] Sánchez-Martínez K.L., Oseguera-Torres L.F., Ávalos-Nuño J. Relationship between the level of maternal glycated hemoglobin and fetal hypertrophic cardiomyopathy // Rev Med Inst Mex Seguro Soc. 2016. Vol. 54, N. 3. P. 260–269.

[67] Babović I, Arandjelović M, Plešinac S, et al. Maternal glycoregulation in pregnancies complicated by diabetes mellitus in the prediction of fetal echography findings and perinatal outcomes. J Obstet Gynaecol Res. 2018;44(3):432–439. doi: 10.1111/jog.13537

[68] Babović I., Arandjelović M., Plešinac S., et al. Maternal glycoregulation in pregnancies complicated by diabetes mellitus in the prediction of fetal echography findings and perinatal outcomes // J Obstet Gynaecol Res. 2018. Vol. 44, N. 3. P. 432–439. doi: 10.1111/jog.13537

RIGHTS & PERMISSIONS

Eсо-Vector